Table S8.
Incidences and HRs with 95% CIs of mortality within 30 days of hip fracture surgery according to selective serotonin reuptake inhibitor (SSRI) use 2006–2016 (N=68,487) after changing the exposure definition
| Events | Incidence (95% CI) | Unadjusted HR (95% CI) | Adjusteda HR (95% CI) | |
|---|---|---|---|---|
| Current user | 1,907 | 13.1 (12.6–13.7) | 1.34 (1.27–1.41) | 1.16 (1.10–1.21) |
| Former user | 137 | 12.3 (10.5–14.4) | 1.25 (1.05–1.48) | 1.12 (0.97–1.30) |
| Non-user | 5,251 | 9.9 (9.7–10.2) | 1.00 | 1.00 |
Notes:
a
Adjusted for age, gender, marital status, operation year, myocardial infarction, congestive heart failure, peripheral vascular disease, dementia, chronic pulmonary disease, connective tissue disease, ulcer disease, liver disease, diabetes type 1 and 2, hemiplegia, moderate to severe renal disease, cancer, non-steroidal anti-inflammatory drugs, corticosteroids, anticoagulants, statins, non-SSRI antidepressants, antipsychotics, and clustering by unit setting.